Registry for Systemic Eczema Treatments
Johns Hopkins University
Summary
The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) who have used or will initiate any systemic treatment(s) for AD. The goal of the registry is to enable more efficient research recruitment and data collection as well as timely notification to enrollees about newly FDA-approved treatments for AD.
Description
The purpose of the Registry for Systemic Eczema Therapies (RESET) registry is to serve as a database and biospecimen repository of patients with pediatric-onset atopic dermatitis (AD), also known as eczema. This registry seeks to enroll patients with AD who have used or will initiate any systemic treatment(s) for AD. Such a registry will allow investigators to identify patients who are potentially eligible for AD research protocols, including observational studies or clinical trials. The registry will also prospectively collect data that would then serve as a resource for studying a variety of…
Eligibility
- Age range
- 1–26 years
- Sex
- All
- Healthy volunteers
- No
Inclusion criteria: * Age \<26 years old * Current physician diagnosis of atopic dermatitis * Provide signed informed consent if ≥ 18 years old * Provide signed informed consent by parent or legal guardian (if \<18 years old) and informed assent if applicable * Subject and/or parent/legal guardian is willing to be contacted in the future by study staff * Seen for clinical care at Johns Hopkins since 1/1/2017 * Previously on, currently on, or planning to initiate (within next 6 months) a systemic AD therapy Exclusion criteria: * Age ≥26 years old at the time of registry enrollment * Does not…
Location
- Johns Hopkins UniversityBaltimore, Maryland